Three pulmonary disease conditions result from the accumulation of phospholipids in the lung. These conditions are the human lung disease known as pulmonary alveolar proteinosis, the lipoproteinosis that arises in the lungs of rats during acute silicosis, and the phospholipidoses induced by numerous cationic amphiphilic therapeutic agents. In this paper, the status of phospholipid metabolism in the lungs during the process of each of these lung conditions has been reviewed and possible mechanisms for their establishment are discussed. Pulmonary alveolar proteinosis is characterized by the accumulation of tubular myelin-like multilamellated structures in the alveoli and distal airways of patients. These structures appear to be formed by a process of spontaneous assembly involving surfactant protein A and surfactant phospholipids. Structures similar to tubular myelin-like multilamellated structures can be seen in the alveoli of rats during acute silicosis and, as with the human condition, both surfactant protein A and surfactant phospholipids accumulate in the alveoli. Excessive accumulation of surfactant protein A and surfactant phospholipids in the alveoli could arise from their overproduction and hypersecretion by a subpopulation of Type II cells that are activated by silica, and possibly other agents. Phospholipidoses caused by cationic amphiphilic therapeutic agents arise as a result of their inhibition of phospholipid catabolism. Inhibition of phospholipases results in the accumulation of phospholipids in the cytoplasm of alveolar macrophages and other cells. While inhibition of phospholipases by these agents undoubtedly occurs, there are many anomalous features, such as the accumulation of extracellular phospholipids and surfactant protein A, that cannot be accounted for by this simplistic hypothesis.
AbeM., AkinoX, and OnoK (1972). The formation of lecithin from lysolecithin in rat lung supernatant.Biochim. Biophys. Acta280: 275–280.
2.
AbeM and AkinoT (1973). The conversion of lysolecithin to lecithin in supernatant fractions of various rat tissues: On the distribution of the so-called Marinetti's enzyme.Tohoku J. Exp. Med.110:167–172.
3.
AbelanetR., GanterP, and StoebnerP (1972). Pulmonary alveolar proteinosis. Morphological, histochemical and ultrastructural study.Ann. Biol. Clin.30: 525–546.
4.
AbrahamJL and McEuenDD (1986). Inorganic particulates associated with pulmonary alveolar proteinosis: SEM and X-ray microanalysis results.Appl. Pathol.4: 138–146.
5.
AdamsonIY and BowdenDH (1974). The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen.Lab. Invest.30: 35–42.
6.
AdamsonIY and BowdenDH (1977). Origin of ciliated alveolar epithelial cells in bleomycin-induced lung injury.Am. J. Pathol.87: 569–580.
7.
AdamsonIY and BowdenDH (1979). Bleomycin-induced injury and metaplasia of alveolar type 2 cells. Relationship of cellular responses to drug presence in the lung.Am. J. Pathol.96: 531–544.
8.
AdamsonIY and BowdenDH (1984). Role of polymorphonuclear leukocytes in silica-induced pulmonary fibrosis.Am. J. Pathol.117: 37–43.
9.
AsoY., YonedaK, and KikkawaY (1976). Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice.Lab. Invest.35: 558–568.
10.
AymardJP, GygerM, LavalleeR, LegresleyLP, and DesyM (1984). A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia. A peculiar pathologic aspect of busulfan lung?Cancer53: 954–956.
11.
BeginR., BergeronD, SamsonL, BoctorM, and CantinA (1987). CT assessment of silicosis in exposed workers.AJR Am. J. Roentgenol.148: 509–514.
12.
BatenburgJJ, LongmoreWJ, KlazingaW, and van GoldeLM (1979). Lysolecithin acyltransferase and lysolecithin: Lysolecithin acyltransferase in adult rat lung alveolar type II epithelial cells.Biochim. Biophys. Acta573: 136–144.
13.
BensonSC, BeltonJC, and ScheveLG (1986). Regulation of lung fibroblast proliferation and collagen synthesis by alveolar macrophages in experimental silicosis. I: Effect of macrophage conditioned medium from silica instilled rats.J. Environ. Pathol. Toxicol. Oncol.7: 87–97.
14.
BertramTA, OverbyLH, BrodyAR, and ElingTE (1989). Comparison of arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages exposed to particulate and soluble stimuli.Lab. Invest.61: 457–466.
15.
BiceDE, HahnFF, BensonJ, CarpenterRL, and HobbsCH (1987). Comparative lung immunotoxicity of inhaled quartz and coal combustion fly ash.Environ. Res.43: 374–389.
16.
BlankML, DalbeyW, NettesheimP, PriceJ, CreasiaD, and SnyderF (1978). Sequential changes in phospholipid composition and synthesis in lungs exposed to nitrogen dioxide.Am. Rev. Respir. Dis.117: 273–280.
17.
BockhardtH., DrenckhahnD, and Liillmann-RauchR (1978). Generalized lipidosis in rats following treatment with amiodarone and zimelidine.Verh. Anat. Ges.72: 417–418.
18.
BrasseurR., CarlierMB, LaurentG, ClaesPJ, VanderhaegheHJ, TulkensPM, and RuysschaertJM (1985). Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities.Biochem. Pharmacol.34: 1035–1047.
19.
BrodyAR (1984). Inhaled particles in human disease and animal models: Use of electron beam instrumentation.Environ. Health Perspect.56: 149–162.
20.
BuffaloeWJ, JohnsonAW, and SandiferMG (1976). Total dosage of chlorpromazine and occular opacities.Am. J. Psych.124: 250–251.
21.
BurchRM (1990). Kinin signal transduction: Role of phosphoinositides and eicosanoids.J. Cardiovasc. Pharmacol.15 Suppl 6: S44–S45.
22.
BurkhardtR., Von WichertP, BatenburgJJ, and Van GoldeLM (1988). Fatty acids stimulate phosphatidylcholine synthesis and CTP:choline-phosphate cytidylyltransferase in type II pneumocytes isolated from adult rat lung.Biochem. J.254: 495–500.
23.
CamnerP., Casarett-BruceM, CurstedtT, JarstrandC, WiernikA, JohanssonA, LundborgM, and RobertsonB (1984). Toxicology of nickel.IARC Sci. Publ.267–276.
24.
CarlierMB, LaurentG, ClaesPJ, VanderhaegheHJ, and TulkensPM (1983). Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: In vitro comparative studies.Antimicrob. Agents Chemother.23: 440–449.
25.
CarlierMB, LaurentG, and TulkensP (1984). In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: A comparative study.Arch. Toxicol. Suppl.7: 282–285.
26.
CarrePC, DidierAP, PipyBR, ForgueMF, BeraudMF, MeeusEP, CarateroAL, and LeophontePJ (1990). The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages.Am. Rev. Respir. Dis.142: 1068–1072.
27.
Casarett-BruceM, CamnerP, and CurstedtT (1981). Changes in pulmonary lipid composition of rabbits exposed to nickel dust.Environ. Res.26: 353–362.
28.
CeruttiP and KapanciY (1979). Effects of metabolite VIII of bromexine (Na 872) on type II epithelium of the lung: An experimental and morphological study with reference to surfactant secretion.Respiration37: 241–251.
29.
ChangLY, GrahamJA, MillerFJ, OspitalJJ, and CrapoJD (1986). Effects of subchronic inhalation of low concentrations of nitrogen dioxide. I. The proximal alveolar region of juvenile and adult rats.Toxicol. Appl. Pharmacol.83: 45–61.
30.
ChauhanSS and MisraUK (1991). Elevation of rat pulmonary, hepatic and lung surfactant lipids by fly ash inhalation.Biochem. Pharmacol.41: 191–198.
31.
ChurgA and WiggsB (1985). Mineral particles, mineral fibers, and lung cancer.Environ. Res.37: 364–372.
32.
ChurgA (1988). Chrysotile, tremolite, and malignant mesothelioma in man.Chest93: 621–628.
33.
CornellR (1989). Chemical crosslinking reveals a dimeric structure for CTP:phosphocholine cytidylyltransferase.J. Biol. Chem.264: 9077–9082.
34.
CostabelU and TeschlerH (1990). Inflammation and immune reactions in interstitial lung disease (ILD) associated with inorganic dust exposure.Eur. Respir. J.3: 363–364.
35.
CostelloJF, MoriartyDC, BranthwaiteMA, Tur-ner-WarwickM, and CorrinB (1975). Diagnosis and management of alveolar proteinosis: The role of electron microscopy.Thorax30: 121–132.
36.
CurstedtT., HagmanM, RobertsonB, and CamnerP (1983). Rabbit lungs after long-term exposure to low nickel dust concentration. I. Effects on phospholipid concentration and surfactant activity.Environ. Res.30: 89–94.
37.
CurstedtT., Casarett-BruceM, and CamnerP (1984). Changes in glycerophosphatides and their ether analogs in lung lavage of rabbits exposed to nickel dust.Exp. Mol. Pathol.41: 26–34.
DakeMD, MadisonJM, MontgomeryCK, ShellitoJE, HinchcliffeWA, WinklerML, and BaintonDF (1985). Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity.Am. J. Med.78: 506–512.
40.
De BroeME, PaulusGJ, VerpootenGA, RoelsF, BuyssensN, WedeenR, Van HoofF, and TulkensPM (1984). Early effects of gentamicin, tobramycin, and amikacin on the human kidney.Kidney Int.25: 643–652.
41.
De BroeME, GiulianoRA, and VerpootenGA (1986). Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.Am. J. Med.80: 115–118.
42.
DeanPJ, GroshartKD, PorterfieidJG, IansmithDH, and GoldenEBJ (1987). Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases.Am. J. Clin. Pathol.87: 7–13.
43.
deShazoRD (1982). Current concepts about the pathogenesis of silicosis and asbestosis.J. Allergy Clin. Immunol.70: 41–49.
44.
DethloffLA, GilmoreLB, GladenBC, GeorgeG, ChhabraRS, and HookGE (1986). Effects of silica on the composition of the pulmonary extracellular lining.Toxicol. Appl. Pharmacol.84: 66–83.
45.
DethloffLA, GilmoreLB, BrodyAR, and HookGE (1986). Induction of intra- and extracellular phospholipids in the lungs of rats exposed to silica.Biochem. J.233: 111–118.
46.
DethloifLA, GilmoreLB, and HookGE (1986). The relationship between intra- and extracellular surfactant phospholipids in the lungs of rabbits and the effects of silica-induced lung injury.Biochem. J.239: 59–67.
47.
DethloffLA, GladenBC, GilmoreLB, and HookGE (1989). Kinetics of pulmonary surfactant phosphatidylcholine metabolism in the lungs of silica-treated rats.Toxicol. Appl. Pharmacol.98: 1–11.
48.
Diez-BlancoMN, Sanchez-YagüeJ, CabezasJA, and LlanilloM (1987). Isolation, characterization and phospholipid composition of lamellar bodies and subcellular fractions from dog lung.Int. J. Biochem.19: 693–698.
49.
DobbsLG, MasonRJ, WilliamsMC, BensonBJ, and SueishiK (1982). Secretion of surfactant by primary cultures of alveolar type II cells isolated from rats.Biochim. Biophys. Acta713: 118–127.
50.
DonaldsonK., BrownGM, BrownDM, SlightJ, RobertsonMD, and DavisJM (1990). Impaired chemotactic responses of bronchoalveolar leukocytes in experimental pneumoconiosis.J. Pathol.160: 63–69.
51.
DzogbefiaVP and GambleW (1986). Alterations in phospholipid biosynthesis by polychlorinated biphenyls and polychlorinated biphenylols.J. Environ. Pathol. Toxicol. Oncol.7: 99–107.
52.
EmersonRJ and DavisGS (1983). Effect of alveolar lining material-coated silica on rat alveolar macrophages.Environ. Health Perspect.51: 81–84.
53.
EskelsonCD, StiffelV, OwenJA, and ChvapilM (1986). The importance of liver in normal and sil-icotic lung-lipid homeostasis. 1. Phospholipids.J. Environ. Pathol. Toxicol. Oncol.6: 37–46.
54.
EskelsonCD, ChvapilM, StromKA, and VostalJJ (1987). Pulmonary phospholipidosis in rats respiring air containing diesel particulates.Environ. Res.44: 260–271.
55.
EskelsonCD, StiffelV, OwenJA, ChvapilM, VickersA, and BrendelK (1988). Changes in the fatty acid profile of lung, liver and serum of rats intratracheally given silica.Life Sci.42: 1455–1467.
56.
FallonJT (1937). Specific tissue reaction to phospholipids: A suggested explanation for the similarity of the lesion of silicosis and tuberculosis.Canad. Med. Assoc. J.36: 223–228.
57.
FeldmanDA, BrubakerPG, and WeinholdPA (1981). Activation of CTP: phosphocholine cytidylyltransferase in rat lung by fatty acids.Biochim. Biophys. Acta665: 53–59.
58.
FeldmanDA and WeinholdPA (1987). CTP:phosphorylcholine cytidylyltransferase from rat liver. Isolation and characterization of the catalytic sub-unit.J. Biol. Chem.262: 9075–9081.
59.
FeldmanDA, RounsiferME, CharlesL, and WeinholdPA (1990). CTP:phosphocholine cytidylyltransferase in rat lung: Relationship between cytosolic and membrane forms.Biochim. Biophys. Acta1045: 49–57.
FosterJR, CottrellRC, HerodIA, AtkinsonHA, and MillerK (1985). A comparative study of the pulmonary effects of NO2 in the rat and hamster.Br. J. Exp. Pathol.66: 193–204.
62.
FringesB., GorgasK, and ReithA (1988). Modifi-cation of surfactant metabolizing cells in rat lung by Clofibrate, a hypolipidemic peroxisome proliferating agent. Evidence to suggest that Clofibrate influences pulmonary surfactant metabolism.Virchows Arch [B].54: 232–240.
63.
FrohD., BallardPL, WilliamsMC, GonzalesJ, GoerkeJ, OdomMW, and GonzalesLW (1990). Lamellar bodies of cultured human fetal lung: Content of surfactant protein A (SP-A), surface film formation and structural transformation in vitro.Biochim. Biophys. Acta1052: 78–89.
64.
GaborS., ZugravuE, KovätsA, BöhmB, and AndrasoniD (1978). Effects of quartz on lung surfactant.Environ. Res.16: 443–448.
65.
GeorgeG and HookGER (1984). The pulmonary extracellular lining.Environ. Health Perspect.55: 227–237.
66.
GeorgeTP, MorashSC, CookHW, ByersDM, PalmerFB, and SpenceMW (1989). Phosphatidylcholine biosynthesis in cultured glioma cells: Evidence for channeling of intermediates.Biochim. Biophys. Acta1004: 283–291.
67.
GeorgeTP, CookHW, ByersDM, PalmerFB, and SpenceMW (1991). Channeling of intermediates in the CDP-choline pathway of phosphatidylcholine biosynthesis in cultured glioma cells is dependent on intracellular Ca2+.J. Biol. Chem.266: 12419–12423.
68.
GhoshS., OtenPW, MukherjeeS, and DasSK (1991). Study of properties of cholinephosphotransferase from fetal guinea pig lung mitochondria and microsomes.Mol. Cell. Biochemis.101: 157–166.
69.
GilmoreLB, TalleyFA, and HookDE (1988). Classification and morphometric quantitation of insoluble materials from the lungs of patients with alveolar proteinosis.Am. J. Pathol.133: 252–264.
70.
GlassrothJL, BernardoJ, LuceyEC, CenterDM, Jung-LeggYJ, and SniderGL (1984). Interstitial pulmonary fibrosis induced in hamsters by intratracheally administered chrysotile asbestos. Histology, lung mechanics, and inflammatory events.Am. Rev. Respir. Dis.130: 242–248.
71.
GoldsmithDF, GuidottiTL, and JohnstonDR (1982). Does occupational exposure to silica cause lung cancer? Am. J. Ind. Med.3: 423–440.
72.
GonmoriK., MoritaT, and MehendaleHM (1986). Effect of chlorphentermine on incorporation of [l4C]choline in the rat lung phospholipids.Lipids21: 230–234.
73.
Gonzalez-RothiRJ and HarrisJO (1986). Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages.Chest90: 656–661.
74.
GordonRE, ShakedAA, and SolanoDF (1986). Taurine protects hamster bronchioles from acute NO2-induced alterations. A histologic, ultrastructural, and freeze-fracture study.Am. J. Pathol.125: 585–600.
75.
GovernaM., ValentinoM, TosiP, LuziP, MiraccoC, SartorelliE, LoiF, FranzinelliA, and GoriR (1986). Pulmonary alveolar lipoproteinosis in rats following intratracheal injection of pyrite particles.J. Toxicol. Environ. Health19: 403–412.
76.
GräbnerR (1987). Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2.Biochem. Pharmacol.36: 1063–1067.
77.
GreenGM (1973). Alveolobronchiolar transport mechanisms.Arch. Intern. Med.131: 109–114.
78.
GremigniD., VannelliG, SgaragliGP, and MengazziniI (1980). Phospholipidosis induced by chlorimipramine in rat lung.Boll. Soc. Ital. Biol. Sper.56: 1078–1082.
79.
GremigniD., VannelliG, SgaragliG, and Delia CorteL (1981). Phospholipidosis of the rat lung following administrations of chlorimipramine.Arch. Ital. Anat. Embriol.86: 37–53.
80.
GrossP., DeTrevilleRT, TolkerEB, KaschakM, and BabyakMA (1967). Experimental asbestosis. The development of lung cancer in rats with pulmonary deposits of chrysotile asbestos dust.Arch. Environ. Health15: 343–355.
81.
GrossP and NauCA (1967). Lignite and the derived steam-activated carbon: The pulmonary response to their dust.Arch. Environ. Health14: 450–460.
82.
GrossP., TumaJ, and DeTrevilleRT (1971). Lungs of workers exposed to fiber glass. A study of their pathologic changes and their dust content.Arch. Environ. Health23: 67–76.
83.
GrossP (1976). The biologic categorization of inhaled fiber glass dust. A critical review of pertinent studies and reports.Arch. Environ. Health31: 101–107.
84.
HaagsmanHP, SchuurmansEA, AlinkGM, BatenburgJJ, and van GoldeLM (1985). Effects of ozone on phospholipid synthesis by alveolar type II cells isolated from adult rat lung.Exp. Lung Res.9: 67–84.
85.
HaagsmanHP, HawgoodS, SargeantT, BuckleyD, WhiteRT, DrickamerK, and BensonBJ (1987). The major lung surfactant protein, SP 28–36, is a calcium-dependent, carbohydrate-binding protein.J. Biol. Chem.262: 13877–13880.
86.
HaagsmanHP, SchuurmansEA, BatenburgJJ, and van GoldeLM (1988). Synthesis of phosphatidylcholines in ozone-exposed alveolar type II cells isolated from adult rat lung: Is glycerolphosphate acyltransferase a rate-limiting enzyme?Exp. Lung Res.14: 1–17.
87.
HaagsmanHP, SargeantT, HauschkaPV, BensonBJ, and HawgoodS (1990). Binding of calcium to SP-A, a surfactant-associated protein.Biochemistry29: 8894–8900.
88.
HackettNA (1983). Cell proliferation in lung following acute fly ash exposure.Toxicology27: 273–286.
89.
HaiesDM, GilJ, and WeibelER (1981). Morphometric study of rat lung cells. I. Numerical and dimensional characteristics of parenchymal cell population.Am. Rev. Respir. Dis.123: 533–541.
90.
HastingsCEJ, DeNicolaDB, RebarAH, TurekJJ, BornGS, and KesslerWV (1987). The effect of chlorphentermine pretreatment on the toxicity of nitrogen dioxide in mice.Fundam. Appl. Toxicol.9: 69–81.
91.
HatchGM, LamTS, TsukitaniY, and VanceDE (1990). Effect of NaF and okadaic acid on the subcellular distribution of CTP: phosphocholine cytidylyltransferase activity in rat liver.Biochim. Biophys. Acta1042: 374–379.
92.
HatchGM, TsukitaniY, and VanceDE (1991). The protein phosphatase inhibitor, okadaic acid, inhibits phosphatidylcholine biosynthesis in isolated rat hepatocytes.Biochim. Biophys. Acta1081: 25–32.
93.
HavenerLJ and TobackFG (1980). Amino acid modulation of renal phosphatidylcholine biosynthesis in the rat.J. Clin. Invest.65: 741–745.
94.
HawgoodS., BensonBJ, SchillingJ, DammD, ClementsJA, and WhiteRT (1987). Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28–36 in surfactant lipid adsorption.Proc. Natl. Acad. Sci. USA84: 66–70.
95.
HayashiY., KohnoT, and OhwadaH (1987). Morphological effects of nitrogen dioxide on the rat lung.Environ. Health Perspect. 13: 135–145.
96.
HeathMF, Costa-JussäFR, JacobsJM, and JacobsonW (1985). The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.Br. J. Exp. Pathol.66: 391–397.
97.
HeathMF and JacobsonW (1985). The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.Lung163: 337–344.
98.
HepplestonAG and YoungAE (1972). Alveolar lipoproteinosis: An ultrastructural comparison of the experimental and human forms.J. Pathol.107:107–117.
99.
HepplestonAG, FletcherK, and WyattI (1974). Changes in the composition of lung lipids and the “turnover” of dipalmitoyl lecithin in experimental alveolar lipoproteinosis induced by inhaled quartz.Br. J. Exp. Pathol.55: 384–395.
100.
HepplestonAG (1975). Animal model of human disease. Pulmonary alveolar lipoproteinosis. Animal model: Silica-induced pulmonary alveolar lipoproteinosis.Am. J. Pathol.78: 171–174.
101.
HoehnSK, LesperanceE, and KlassDJ (1983). Enzymes of phospholipid biosynthesis in rat alveolar type II cells.Lung161: 229–234.
102.
HollandLM (1990). Crystalline silica and lung cancer: A review of recent experimental evidence.Reg. Toxicol. Pharmacol.12: 224–237.
103.
HolmBA, MatalonS, FinkelsteinJN, and NotterRH (1988). Type II pneumocyte changes during hyperoxic lung injury and recovery.J. Appl. Physiol.65: 2672–2678.
104.
HookGE, BellDY, GilmoreLB, NadeauD, ReasorMJ, and TalleyFA (1978). Composition of bronchoalveolar lavage effluents from patients with pulmonary alveolar proteinosis.Lab. Invest.39: 342–357.
105.
HookGE, GilmoreLB, and TalleyFA (1984). Multilamelled structures from the lungs of patients with pulmonary alveolar proteinosis.Lab. Invest. 50:711–725.
106.
HookGER, SpaldingJW, OrtnerMJ, TombropoulosEG, and ChignellCF (1984). Investigation of phospholipids of the pulmonary extracellular lining by electron paramagnetic resonance: The effects of phosphatidylglycerol and unsaturated phosphatidylcholines on the fluidity of dipalmitoylphosphatidylcholine.Biochem. J.223: 533–542.
107.
HookGE, GilmoreLB, and TalleyFA (1986). Dis-solution and reassembly of tubular myelin-like multilamellated structures from the lungs of patients with pulmonary alveolar proteinosis.Lab. Invest.55: 194–208.
108.
HoriuchiT., MasonRJ, KurokiY, and CherniackRM (1990). Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat.Am. Rev. Respir. Dis.141: 1006–1013.
109.
HosakaK., KodakiT, and YamashitaS (1989). Cloning and characterization of the yeast CKI gene encoding choline kinase and its expression in Escherichia coli.J. Biol. Chem.264: 2053–2059.
110.
HostetlerKY and MatsuzawaY (1981). Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C.Biochem. Pharmacol.30: 11121–1126.
111.
HostetlerKY, ReasorMJ, WalkerER, YazakiPJ, and FrazeeBW (1986). Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats.Biochim. Biophys. Acta875: 400–405.
112.
HrubanZ., SlesersA, and HopkinsE (1972). Drug-induced and naturally occurring myeloid bodies.Lab. Invest.27: 62–70.
113.
HrubanZ., SlesersA, and AschenbrennerI (1973). Pulmonary intra-alveolar histiocytosis induced by drugs.Toxicol. Appl. Pharmacol.26: 72–85.
114.
HrubanZ (1976). Pulmonary changes induced by amphophilic drugs.Environ. Health Perspect.16: 111–118.
115.
HrubanZ (1984). Pulmonary and generalized lysosomal storage induced by amphiphilic drugs.Environ. Health Perspect.55: 53–76.
116.
IshidateK., NakagomiK, and NakazawaY (1984). Complete purification of choline kinase from rat kidney and preparation of rabbit antibody against rat kidney choline kinase.J. Biol. Chem.259: 14706–14710.
117.
IshidateK., FurusawaK, and NakazawaY (1985). Complete co-purification of choline kinase and ethanolamine kinase from rat kidney and immunological evidence for both kinase activities residing on the same enzyme protein(s) in rat tissues.Biochim. Biophys. Acta836: 119–124.
118.
IshidateK., IidaK, TadokoroK, and NakazawaY (1985). Evidence for the existence of multiple forms of choline (ethanolamine) kinase in rat tissues.Biochim. Biophys. Acta833: 1–8.
119.
JacobsH., JobeA, IkegamiM, MillerD, and JonesS (1984). Reutilization of phosphatidylcholine an-alogues by the pulmonary surfactant system. The lack of specificity.Biochim. Biophys. Acta793: 300–309.
120.
JamilH and VanceDE (1990). Head-group specificity for feedback regulation of CTP:phosphocholine cytidylyltransferase.Biochem. J.270: 749–754.
121.
JamilH., YaoZM, and VanceDE (1990). Feedback regulation of CTP:phosphocholine cytidylyltransferase translocation between cytosol and endoplasmic reticulum by phosphatidylcholine.J. Biol. Chem.265: 4332–4339.
122.
JobeA., IkegamiM, Sarton-MillerI, JonesS, and YuG (1981). Characterization of phospholipids and localization of some phospholipid synthetic and subcellular marker enzymes in subcellular fractions from rabbit lung.Biochim. Biophys. Acta666: 47–57.
123.
JohanssonA., CamnerP, JarstrandC, and WiernikA (1983). Rabbit alveolar macrophages after inhalation of soluble cadmium, cobalt, and copper: A comparison with the effects of soluble nickel.Environ. Res.31: 340–354.
124.
JohanssonA., CurstedtT, RobertsonB, and CamnerP (1983). Rabbit lung after inhalation of soluble nickel. II. Effects on lung tissue and phospholipids.Environ. Res.31: 399–412.
125.
JohanssonA., CurstedtT, RobertsonB, and CamnerP (1984). Lung morphology and phospholipids after experimental inhalation of soluble cadmium, copper, and cobalt.Environ. Res.34: 295–309.
126.
JohanssonA and CamnerP (1986). Adverse effects of metals on the alveolar part of the lung.Scan. Electron Microsc. Pt 2: 631–637.
127.
JohanssonA., CurstedtT, RobertsonB, and CamnerP (1989). Lung lesions after experimental combined exposure to nickel and trivalent chromium.Environ. Res.50: 103–119.
128.
JonesWP, ShinMS, StanleyRJ, and Duncan-MyersJ (1985). Dense liver in a 72-year-old woman with congestive heart failure. Invest. Radiol. 20: 911–915. Radiol.20: 911–915.
129.
JordanaM., RichardsC, IrvingLB, and GauldieJ (1988). Spontaneous in vitro release of alveolarmacrophage cytokines after the intratracheal instillation of bleomycin in rats. Characterization and kinetic studies.Am. Rev. Respir. Dis.137: 1135–1140.
130.
JoshiUM, KodavantiPR, CoudertB, DwyerTM, and MehendaleHM (1988). Types of interaction of amphiphilic drugs with phospholipid vesicles.J. Pharmacol. Exp. Ther.246: 150–157.
131.
JoshiUM, RaoP, KodavantiS, LockardVG, and MehendaleHM (1989). Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: Relevance to phospholipidosis.Biochim. Biophys. Acta1004: 309–320.
132.
KacewS (1985). Gentamicin or chlorphentermine induction of phospholipidosis in the developing or-ganism: Role of tissue and species in manifestation of toxicity.J. Pharmacol. Exp. Ther.232: 239–243.
133.
KacewS (1987). Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: An in vivo comparative study with gentamicin and chlorphentermine.Toxicol. Appl. Pharmacol.91: 469–476.
134.
KacewS (1988). Role of phospholipase C in chlorphentermine-induced pulmonary phospholipidosis in rat.Proc. Soc. Exp. Biol. Med.188: 35–39.
135.
KalmarGB, KayRJ, LachanceA, AebersoldR, and CornellRB (1990). Cloning and expression of rat liver CTP: phosphocholine cytidylyltransferase: An amphipathic protein that controls phosphatidylcholine synthesis.Proc. Natl. Acad. Sci. USA87: 6029–6033.
136.
KannanR., SarmaJS, GuhaM, and VenkataramanK (1991). Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats.Fundam. Appl. Toxicol.16: 103–109.
137.
KarabelnikD and ZbindenG (1975). Drug-induced foam cell reactions in rats, II. Chemical analysis of lipids stored in lungs and foam cells after treatment with chlorphentermine, 5-[p-(fluoren-9-ylidene-methyl)phenyl]-2-piperidineethanol (RMI 10.393) and 1-chloramitriptyline.Hoppe Seylers Z. Physiol. Chem.356: 1151–1160.
138.
KarabelnikD and ZbindenG (1976). Palmitic acid-1-14C incorporation and turnover in lung phospholipids of rats treated with chlorphentermine, RMI 10.393 and Ro 4-4318.Arch. Toxicol.35: 163–174.
139.
KawadaH., HoriuchiT, ShannonJM, KurokiY, VoelkerDR, and MasonRJ (1989). Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in the rat.Am. Rev. Respir. Dis.140: 460–470.
140.
KawadaH., ShannonJM, and MasonRJ (1990). Improved maintenance of adult rat alveolar type II cell differentiation in vitro: Effect of serum-free, hormonally defined medium and a reconstituted basement membrane.Am. J. Respir. Cell Mol. Biol.3: 33–43.
141.
KazarianPA and KaragezianKG (1986). Phospholipid biosynthesis in the lungs in a chronic inflammatory bronchopulmonary process.Biull. Eksp. Biol. Med.101: 296–298.
142.
KikkawaY and SuzukiK (1972). Alteration of cellular and acellular alveolar and bronchiolar walls produced by hypocholesteremic drug AY9944.Lab. Invest.26: 441–447.
143.
KikkawaY and MotoyamaEK (1973). Effect of AY-9944, a cholesterol biosynthesis inhibitor, on fetal lung development and on the development of type II alveolar epithelial cells.Lab. Invest.28: 48–54.
144.
KirbyTS (1967). Cataracts produced by triparanol (MER/29).Trans. Am. Ophthalmol. Soc.65: 493–543.
145.
KodavantiUP, LockardVG, and MehendaleHM (1990). In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats.J. Biochem. Toxicol.5:245–251.
146.
KodavantiUP and MehendaleHM (1990). Cationic amphiphilic drugs and phospholipid storage disorders.Pharmacol. Revs.42: 327–354.
147.
KodavantiUP and MehendaleHM (1991). Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung.Am. J. Respir. Cell Mol. Biol.4: 369–378.
148.
KoizumiH., WatanabeM, NumataH, SakaiT, and MorishitaH (1986). Species differences in vacuolation of the choroid plexus induced by the piperidine-ring drug disobutamide in the rat, dog, and monkey.Toxicol. Appl. Pharmacol.84: 125–148.
149.
KolesnickRN and HemerMR (1990). Physiologic 1,2-diacylglycerol levels induce protein kinase C-independent translocation of a regulatory enzyme.J. Biol. Chem.265: 10900–10904.
150.
KorfhagenTR, GlasserSW, BrunoMD, McMahanMJ, and WhitsettJA (1991). A portion of the human surfactant protein A (SP-A) gene locus consists of a pseudogene.Am. J. Respir. Cell. Mol. Biol.4: 463–469.
151.
KornbrustDJ and HatchGE (1984). Effect of silica and volcanic ash on the content of lung alveolar and tissue phospholipids.Environ. Res.35: 140–153.
152.
KreschMJ, SmartDA, WilsonCM, GrossI, and RooneySA (1988). Activities of enzymes of phospholipid and fatty acid synthesis in fetal and adult rat type II pneumocytes.Biochim. Biophys. Acta962: 173–177.
153.
KuhnC., GyörkeyF, LevineBE, and Ramirez-Ri-veraJ (1966). Pulmonary alveolar proteinosis. A study using enzyme histochemistry, electron microscopy, and surface tension measurement.Lab. Invest.15: 492–509.
154.
KumarRK, TruscottJY, HristoforidisCP, SmithGJ, and LykkeAW (1986). Altered morphology, growth, and biosynthetic activity of a type 2 pneumocyte-related cell strain induced by lymphokine-enriched supernatants of mitogen-stimulated spleen cells.Exp. Lung Res.11: 129–144.
155.
LanglossJM, HooverEA, and KahnDE (1977). Diffuse alveolar damage in cats induced by nitrogen dioxide or feline calicivirus.Am. J. Pathol.89: 637–648.
156.
LaurentG., CarlierMB, RollmanB, Van HoofF, and TulkensP (1982). Mechanism of aminoglycoside-induced lysosomal phospholipidosis: In vitro and in vivo studies with gentamicin and amikacin.Biochem. Pharmacol.31: 3861–3870.
157.
LeeKP, TrochimowiczHJ, and ReinhardtCF (1985). Pulmonary response of rats exposed to titanium dioxide (Ti02) by inhalation for two years.Toxicol. Appl. Pharmacol.79: 179–192.
158.
LeeKP and GilliesPJ (1986). Pulmonary response and intrapulmonary lipids in rats exposed to bis-muth orthovanadate dust by inhalation.Environ. Res.40: 115–135.
159.
LeeKP, HenryNW, TrochimowiczHJ, and ReinhardtCF (1986). Pulmonary response to impaired lung clearance in rats following excessive Ti02 dust deposition.Environ. Res.41: 144–167.
160.
LeeKP, KellyDP, SchneiderPW, and TrochimowiczHJ (1986). Inhalation toxicity study on rats exposed to titanium tetrachloride atmospheric hydrolysis products for two years.Toxicol. Appl. Pharmacol.83: 30–45.
161.
LeeKP, UlrichCE, GeilRG, and TrochimowiczHJ (1988). Effects of inhaled chromium dioxide dust on rats exposed for two years.Fundam. Appl. Toxicol.10: 125–145.
162.
LeeKP, UlrichCE, GeilRG, and TrochimowiczHJ (1989). Inhalation toxicity of chromium dioxide dust to rats after two years exposure.Sci. Total Environ.86: 83–108.
163.
LewisRW, HarwoodJL, and RichardsRJ (1987). The fate of instilled pulmonary surfactant in normal and quartz-treated rats.Biochem. J.243: 679–685.
164.
LewisJ and JobeA (1989). Metabolism of intratracheally administered unsaturated phosphatidylcholines in adult rabbits.Biochim. Biophys. Acta1005: 277–281.
165.
LowRB, AdlerKB, Woodcock-MitchellJ, GiancolaMS, and VacekPM (1988). Bronchoalveolar lavage lipids during development of bleomycin-induced fibrosis in rats. Relationship to altered epithelial cell morphology.Am. Rev. Respir. Dis.138: 709–713.
166.
LüllmanH, Lüllman-RauchR, and ReilGH (1973). A comparative ultrastructural study of the effects of chlorphentermine and triparanol in rat lung and adrenal gland.Virchows. Arch. (Cell Pathol.)12: 91–103.
167.
LüllmannH and Lüllmann-RauchR (1978). Perhexiline induces generalized lipidosis in rats.Klin. Wochenschr.56: 309–310.
168.
LüllmannH, Lüllmann-RauchR, and MosingerEU (1981). Impairment of renal function in rats with generalized lipidosis as induced by chlorphentermine.Arzneimittelforschung31: 795–799.
169.
Lüllmann-RauchR and ScheidD (1975). Intralveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs.Virchows. Arch. (Cell Pathol.)19: 255–268.
170.
Lüllmann-RauchR (1979). Drug-induced lysosomal storage disorders. In: Lysosomes in Biology and Pathology, DingleJT, JacquesPJ, ShawIH, (eds). North-Holland, New York, pp. 49–130.
171.
MaJY, MaJK, WeberKC, BowmanL, ReasorMJ, and MilesPR (1988). Association of chlorphentermine with phospholipids in rat alveolar lavage materials, alveolar macrophages and type II cells.Biochim. Biophys. Acta958: 163–171.
172.
MaJY, LaCagninLB, BowmanL, and MilesPR (1989). Carbon tetrachloride inhibits synthesis of pulmonary surfactant disaturated phosphatidylcholines and ATP production in alveolar type II cells.Biochim. Biophys. Acta1003: 136–144.
173.
MagesF., MacovschiO, PrigentAF, and FonluptP (1989). Increased methylation of chloroform extractable products and CTP: choline-phosphate cytidylyltransferase in brain membrane preparations from triethyltin-intoxicated rats.Pharmacol. Toxicol.65: 302–305.
174.
MagnussonG and MagnussonO (1972). Cloforex-induced pulmonary changes in rats.Beitr. Pathol.146: 79–88.
175.
MagnussonG., OlssonT, and NybergJA (1986). Toxicity of Pluronic F-68.Toxicol. Lett.30: 203–207.
176.
MansbachCM and ParthasarathyS (1979). Regulation of de novo phosphatidylcholine synthesis in rat intestine.J. Biol. Chem.254: 9688–9694.
177.
MarcheP., KoutouzovS, and GirardA (1983). Impairment of membrane phosphoinositide metabolism by aminoglycoside antibiotics: Streptomycin, amikacin, kanamycin, dibekacin, gentamicin and neomycin.J. Pharmacol. Exp. Ther.227: 415–420.
178.
MartinWJ, OsbornMJ, and DouglasWW (1985). Amiodarone pulmonary toxicity. Assessment by bronchoalveolar lavage.Chest88: 630–631.
179.
MartinWJ and StandingJE (1988). Amiodarone pulmonary toxicity: Biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.J. Pharmacol. Exp. Ther.244: 774–779.
180.
MartinWJ, KachelDL, VilenT, and NatarajanV (1989). Mechanism of phospholipidosis in amiodarone pulmonary toxicity.J. Pharmacol. Exp. Ther.251: 272–278.
181.
MazueG., BertheJ, NewmannAJ, and BrunaudM (1981). A toxicologic evaluation of ethyl fluclozepate (CM 6912).Int. J. Clin. Pharmacol. Ther. Toxicol.19: 453–472.
182.
McCunneyRJ and GodefroiR (1989). Pulmonary alveolar proteinosis and cement dusk: A case report.J. Occup. Med.31:233–237.
183.
McKeownCA, SwartzM, BlomJ, and MaggianoJM (1981). Tamoxifen retinopathy.Br. J. Ophthalmol.65: 177–179.
184.
McNultyMJ and ReasorMJ (1981). Iprindole-induced phospholipidosis in rat alveolar macrophages: Alterations in oxygen consumption and release of oxidants.Exp. Lung Res.2: 57–69.
185.
MeerbachW., GräbnerR, DietzW, and BöttgerW (1982). A comparative morphological and chemical study of the ambroxol and chlorphentermine action on the lung phospholipid content (author's transl.).Zentralbl. Allg. Pathol.126: 185–195.
186.
MerrillAH (1989). Lipid modulators of cell function.Nutr. Rev.41: 161–169.
187.
MerrillWW, CarterD, and CullenMR (1991). The relationship between large airway inflammation and airway metaplasia.Chest100: 131–135.
188.
MilesPR, BowmanL, TuckerJ, ReasorMJ, and WrightJR (1986). Alterations in rat alveolar surfactant phospholipids and proteins induced by administration of chlorphentermine.Biochim. Biophys. Acta877: 167–178.
189.
MillerBE, DethloffLA, and HookGE (1986). Silica-induced hypertrophy of type II cells in the lungs of rats.Lab. Invest.55: 153–163.
190.
MillerBE, ChapinRE, PinkertonKE, GilmoreLB, MaronpotRR, and HookGE (1987). Quantitation of silica-induced type II cell hyperplasia by using alkaline phosphatase histochemistry in glycol methacrylate embedded lung.Exp. Lung Res.12: 135–148.
191.
MillerBE, DethloffLA, GladenBC, and HookGE (1987). Progression of type II cell hypertrophy and hyperplasia during silica-induced pulmonary inflammation.Lab. Invest.57: 546–554.
192.
MillerBE and HookGE (1988). Isolation and characterization of hypertrophic type II cells from the lungs of silica-treated rats.Lab. Invest.58: 565–575.
193.
MillerBE and HookGE (1988). Stimulation of surfactant phospholipid biosynthesis in the lungs of rats treated with silica.Biochem. J.253: 659–665.
194.
MillerBE and HookGE (1989). Regulation of phosphatidylcholine biosynthesis in activated alveolar type II cells.Am. J. Respir. Cell. Mol. Biol.1: 127–136.
195.
MillerBE, BakewellWE, KatyalSL, SinghG, and HookGE (1990). Induction of surfactant protein (SP-A) biosynthesis and SP-A mRNA in activated type II cells during acute silicosis in rats.Am. J. Respir. Cell. Mol. Biol.3: 217–226.
196.
MillerBE and HookGE (1990). Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants.Environ. Health Perspect.85: 15–23.
197.
MinchinRF, IlettKF, and MadsenBW (1979). Chlorphentermine binding in rat lung subcellular fractions and its displacement by desmethylimipramine.Biochem. Pharmacol.28: 2273–2278.
198.
NarayanS., DaniHM, and MisraUK (1989). Induction of phosphatidylcholine biosynthesis via CDPcholine pathway in lung and liver of rats following intratracheal administration of DDT and endosulfan.J. Biochem. Toxicol.4: 205–210.
199.
NarayanS., DaniHM, and MisraUK (1990). Lung subcellular fractions and surfactant lipid metabolism of rats exposed with DDT or endosulfan intratracheally.J. Environ. Sci. Health [B].25: 259–272.
200.
NickJ., DudognonP, EscourolleR, BakoucheP, NicolleMH, ReignierA, HauwJJ, ErmidouS, PolletS, and BaumannN (1978). Neurological disorders and perhexiline maleate therapy. Clinical study of 10 cases. Neuropathological, pharmacocinetic and biochemical studies.Rev. Neurol.134: 103–114.
201.
OgleCL and ReasorMJ (1990). Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro. Toxicology62: 227–238.
202.
OkanoA., SatoA, ChidaK, IwataM, YasudaK, ShichiI, and SudaT (1990). Improvement in alveolar macrophage function after therapeutic lung lavage in pulmonary alveolar proteinosis.Nippon Kyobu Shikkan Gakkai Zasshi28: 723–728.
203.
Oosterlaken-DijksterhuisMA, van EijkM, van BuelBL, van GoldeLM, and HaagsmanHP (1991). Surfactant protein composition of lamellar bodies isolated from rat lung.Biochem. J.274: 115–119.
204.
PappuAS, YazakiPJ, and HostetierKY (1985). Inhibition of purified lysosomal phospholipase A, by beta-adrenoceptor blockers.Biochem. Pharmacol.34: 521–524.
205.
PieterseAS, RowlandR, and DunnD (1983). Perhexiline maleate induced cirrhosis.Pathology15: 201–203.
206.
PinkertonKE, YoungSL, FramEK, and CrapoJD (1990). Alveolar type II cell responses to chronic inhalation of chrysotile asbestos in rats.Am. J. Respir. Cell. Mol. Biol.3: 543–552.
207.
PorterTJ and KentC (1990). Purification and characterization of choline/ethanolamine kinase from rat liver.J. Biol. Chem.265: 414–422.
208.
PossmayerF (1988). A proposed nomenclature for pulmonary surfactant-associated proteins.Am. Rev. Respir. Dis.138: 990–998.
209.
PostM., BatenburgJJ, SchuurmansEA, and Van GoldeLM (1982). The rate-limiting step in the biosynthesis of phosphatidylcholine by alveolar type II cells from adult rat lung.Biochim. Biophys. Acta712: 390–394.
210.
PostM., BatenburgJJ, Van GoldeLM, and SmithBT (1984). The rate-limiting reaction in phosphatidylcholine synthesis by alveolar type II cells isolated from fetal rat lung.Biochim. Biophys. Acta795: 558–563.
211.
PostM., TordayJS, and SmithBT (1984). Alveolar type II cells isolated from fetal rat lung organotypic cultures synthesize and secrete surfactant-associated phospholipids and respond to fibroblast-pneumonocyte factor.Exp. Lung Res.7: 53–65.
212.
PostM., BarsoumianA, and SmithBT (1986). The cellular mechanism of glucocorticoid acceleration of fetal lung maturation. Fibroblast-pneumonocyte factor stimulates choline-phosphate cytidylyltransferase activity.J. Biol. Chem.261: 2179–2184.
213.
PozziE., SalmonaM, MasturzoP, GenghiniM, ScelsiM, SpialtiniL, and LuisettiM (1987). Role of alveolar phospholipids in bleomycin-induced pulmonary fibrosis in the rat.Respiration51 Suppl 1: 23–32.
214.
RabkinSW (1989). Effects of chlorpromazine and trifluoperazine on choline metabolism and phosphatidylcholine biosynthesis in cultured chick heart cells under normoxic and anoxic conditions.Biochem. Pharmacol.38: 2349–2355.
215.
RamiJ., SasicSM, and RooneySA (1991). Enhanced fatty acid biosynthesis and normal surfactant secretion in hypertrophic rat type II cells.Am. J. Physiol.260: L577–L585.
216.
RamirezJ and HarlanWRJ (1968). Pulmonary alveolar proteinosis. Nature and origin of alveolar lipid.Am. J. Med.45: 502–512.
217.
ReasorMJ (1981). Chlorphentermine-induced phospholipidosis in rat alveolar macrophages—Luminol-dependent chemiluminescence.Biochem. Pharmacol.30: 165–168.
218.
ReasorMJ and CastranovaV (1981). Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: Biochemical and cellular features.Exp. Mol. Pathol.35: 359–369.
219.
ReasorMJ, HeynemanCA, and WalkerER (1982). Chlorcyclizine—Induced pulmonary phospholipidosis in rats.Res. Commun. Chem. Pathol. Pharmacol.38: 235–246.
220.
RiceWR, SarinVK, FoxJL, BaatzJ, WertS, and WhitsettJA (1989) Surfactant peptides stimulate uptake of phosphatidylcholine by isolated cells.Biochim. Biophys. Acta1006: 237–245.
221.
Rola-PleszczynskiM, GouinS, and BëginR (1984). Asbestos-induced lung inflammation. Role of local macrophage-derived chemotactic factors in accumulation of neutrophils in the lungs.Inflammation8: 53–62.
222.
RomWN, TravisWD, and BrodyAR (1991). Cellular and molecular basis of the asbestos-related diseases.Am. Rev. Respir. Dis.143: 408–422.
223.
RooneySA, CanavanPM, and MotoyamaEK (1974). The identification of phosphatidylglycerol in the rat, rabbit, monkey and human lung.Biochim. Biophys. Acta360: 56–67.
224.
RooneySA, NardoneLL, ShapiroDL, MotoyamaEK, GobranL, and ZaehringerN (1977). The phospholipids of rabbit type II alveolar epithelial cells: Comparison with lung lavage, lung tissue, alveolar macrophages, and a human alveolar tumor cell line.Lipids12: 438–442.
225.
RooneySA, DyniaDW, SmartDA, ChuAJ, InglesonLD, WilsonCM, and GrossI (1986). Glu-cocorticoid stimulation of choline-phosphate cytidylyltransferase activity in fetal rat lung: Receptor-response relationships.Biochim. Biophys. Acta888: 208–216.
226.
RooneySA, SmartDA, WeinholdPA, and FeldmanDA (1990). Dexamethasone increases the activity but not the amount of choline-phosphate cytidylyltransferase in fetal rat lung.Biochim. Biophys. Acta1044: 385–389.
227.
RosenSH, CastlemanB, and LiebowAA (1958). Pulmonary alveolar proteinosis.New Engl. J. Med.258: 1123–1142.
228.
RossGF, OhningBL, TannenbaumD, and WhitsettJA (1987). Structural relationships of the major glycoproteins from human alveolar proteinosis surfactant.Biochim. Biophys. Acta911: 294–305.
229.
RyrfeldtA (1970). The distribution, elimination, and biotransformation of 14C-cloforex in the mouse and rat.Acta Pharmacol. Toxicol.28: 391–405.
230.
SandströmT, AnderssonMC, Kolmodin-HedmanB, StjernbergN, and AngströmT (1990). Bronchoalveolar mastocytosis and lymphocytosis after nitrogen dioxide exposure in man: A time-kinetic study.Eur. Respir. J.3: 138–143.
231.
SangheraJS and VanceDE (1989). CTP:phosphocholine cytidylyltransferase is a substrate for cAMP-dependent protein kinase in vitro.J. Biol. Chem.264: 1215–1223.
232.
SchimmelpfengJ and SeidelA (1991). Cytotoxic effects of quartz and chrysotile asbestos: In vitro interspecies comparison with alveolar macrophages. J.Toxicol. Environ. Health33: 131–140.
233.
SchlameM., RüstowB, and KunzeD (1989). Synthesis of phosphatidylcholine and phosphatidylglycerol in rat lung mitochondria.Mol. Cell Biochem.85: 115–122.
234.
SchoenbergerC., HunninghakeG, GadekJ, and CrystalR (1981). Inflammation and asbestosis: Characterization and maintenance of alveolitis following acute asbestos exposure.Chest80: 70–71.
235.
SchwartzDA, GalvinJR, DaytonCS, StanfordW, MerchantJA, and HunninghakeGW (1990). Determinants of restrictive lung function in asbestos-induced pleural fibrosis.J. Appl. Physiol.68: 1932–1937.
236.
SeilerKU and WassermannO (1975). Drug-induced phospholipidosis. II. Alterations in the phospholipid pattern of organs from mice, rats and guinea-pigs after chronic treatment with chlorphentermine.Naunyn Schmiedebergs Arch. Pharmacol.288: 261–268.
237.
SgaragliGP, Delia CorteL, and GremigniD (1983). Chlorimipramine-induced phospholipidosis: Biochemical and pharmacokinetic observations in the rat.Pharmacol. Res. Commun.15: 231–246.
238.
ShaikhNA, DownarE, and ButanyJ (1987). Amiodarone—An inhibitor of phospholipase activity: A comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine.Mol. Cell Biochem.76: 163–172.
239.
ShamiSG, EvansMJ, and MartinezLA (1986) Type II cell proliferation related to migration of inflammatory cells into the lung.Exp. Mol. Pathol.44: 344–352.
SikpiMO and DasSK (1987). The localization of cholinephosphotransferase in the outer membrane of guinea-pig lung mitochondria.Biochim. Biophys. Acta899: 35–43.
242.
SjöstrandM, RylanderR, and BergströmR (1989). Lung cell reactions in guinea pigs after inhalation of asbestos (amosite).Toxicology57: 1–14.
243.
SohalPS and CornellRB (1990). Sphingosine inhibits the activity of rat liver CTP:phosphocholine cytidylyltransferase.J. Biol. Chem.265: 11746–11750.
244.
TakemuraT., FukudaY, HarrisonM, and FerransVJ (1987). Ultrastructural, histochemical, and freeze-fracture evaluation of multilamellated structures in human pulmonary alveolar proteinosis.Am. J. Anat.179: 258–268.
245.
TashiroT., GotoJ, GotoI, AkashiM, NasuM, ItogaT, NakamuraH, HondaY, HondaN, and HadamaT (1983). Case of pulmonary alveolar proteinosis with silicosis.Nippon Kyobu Shikkan Gakkai Zasshi21: 591–595.
246.
TetleyTD, RichardsRJ, and HarwoodJL (1977). Changes in pulmonary surfactant and phosphatidylcholine metabolism in rats exposed to chrysotile asbestos dust.Biochem. J.166: 323–329.
247.
ThelmoWL and LevineS (1978). Renal lesions induced by tilorone and an analog. Ultrastructure and acid phosphatase study.Am. J. Pathol91:355–360.
248.
Thoma-LaurieDL, WalkerER, and ReasorMJ (1983). Chlorphentermine-induced neonatal and maternal pulmonary phospholipidosis in rats.Exp. Mol. Pathol.38: 310–321.
249.
ThompsonSW (1975). Chloroquine retinopathy in the rat.Vet. Pathol.12: 71.
250.
TigheD., MossR, BoghossianS, HeathMF, ChessumB, and BennettED (1989). Multi-organ damage resulting from experimental faecal peritonitis.Clin. Sci.76: 269–276.
251.
TsukagoshiY., NikawaJ, and YamashitaS (1987). Molecular cloning and characterization of the gene encoding choline-phosphate cytidylyltransferase in Saccharomyces cerevisiae.Eur. J. Biochem.169: 477–486.
252.
UhalBD and LongmoreWJ (1988). Glycerol as a substrate for phospholipid biosynthesis in type II pneumocytes isolated from streptozotocin-diabetic rats.Biochim. Biophys. Acta961: 122–128.
253.
Van den BoschH, BonteHA, and Van DeenanLLM (1965). On the anabolism of lysolecithin.Biochim. Biophys. Acta280: 648–652.
254.
Van HeusdenGP and Van den BoschH (1981). Comparison of ACYL-CoA: lysophosphatidylcholine acyltransferase and lysophosphatidylcholine: lysophosphatidylcholine transacylase activity in various mammalian lungs.Biochim. Biophys. Acta666: 508–511.
255.
VanceDE (1990). Boehringer Mannheim Award lecture. Phosphatidylcholine metabolism: Maso-chistic enzymology, metabolic regulation, and lipoprotein assembly.Biochem. Cell Biol.68:1151–1165.
256.
VijeyaratnamGS and CorrinB (1971). Experimental paraquat poisoning: A histological and electron-optical study of the changes in the lung.J. Pathol.103: 123–129.
257.
VindingT and NielsenNV (1983). Retinopathy caused by treatment with tamoxifen in low dosage.Acta Ophthalmol.61: 45–50.
258.
VoelkerDR and SnyderF (1979). Subcellular site and mechanism of synthesis of disaturated phosphatidylcholine in alveolar type II cell adenomas.J. Biol. Chem.254: 8628–8633.
259.
von WichertP, BavendammU, von TeichmannM, MüllerG, ThalheimE, WilkeA, and WiegersU (1977). Increased incorporation of fatty acids into phospholipids of lungs and livers of rabbits under the influence of bromhexine and ambroxol.Naunyn Schmiedebergs Arch Pharmacol.297: 269–273.
260.
VysköcilJ and TumaJ (1967). Experimental study of the elimination of dust from the lungs. VI. Effect of acute inflammation produced by diazomethane on the pulmonary distribution and elimination of quartz dust in rabbits.Poumon Coeur23: 1293–1302.
261.
WarrRG, HawgoodS, BuckleyDI, CrispTM, SchillingJ, BensonBJ, BallardPL, ClementsJA, and WhiteRT (1987). Low molecular weight human pulmonary surfactant protein (SP5): Isolation, characterization, and cDNA and amino acid sequences.Proc. Natl. Acad. Sci. USA84: 7915–7919.
262.
WatkinsJD and KentC (1990). Phosphorylation of CTP:phosphocholine cytidylyltransferase in vivo. Lack of effect of phorbol ester treatment in HeLa cells.J. Biol. Chem.265: 2190–2197.
263.
WebbDR, WilsonSE, and CarterDE (1986). Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats.Toxicol. Appl. Pharmacol.82:405–416.
264.
WehnerAP, DagleGE, ClarkML, and BuschbomRL (1986). Lung changes in rats following inhalation exposure to volcanic ash for two years.Environ. Res.40:499–517.
265.
WeinholdPA, RounsiferME, and FeldmanDA (1986). The purification and characterization of CTP: phosphorylcholine cytidylyltransferase from rat liver.J. Biol. Chem.261: 5104–5110.
266.
WeinholdPA, RounsiferME, CharlesL, and FeldmanDA (1989). Characterization of cytosolic forms of CTP:choline-phosphate cytidylyltransferase in lung, isolated alveolar type II cells, A549 cell and Hep G2 cells.Biochim. Biophys. Acta1006: 299–310.
267.
WeinholdPA, CharlesL, RounsiferME, and FeldmanDA (1991). Control of phosphatidylcholine synthesis in Hep G2 cells. Effect of fatty acids on the activity and immunoreactive content of choline phosphate cytidylyltransferase.J. Biol. Chem.266: 6093–6100.
268.
WeissJN, WeinbergRS, and RegelsonW (1980). Keratopathy after oral administration of tilorone hydrochloride.Am. J. Ophthalmol.89: 46–53.
269.
WellwoodJM and TigheJR (1975). Proceedings: Evidence of gentamicin nephrotoxicity in patients with renal allografts.Br. J. Surg.62: 156.
270.
WellwoodJM, LovellD, ThompsonAE, and TigheJR (1976). Renal damage caused by gentamicin: A study of the effects on renal morphology and urinary enzyme excretion.J. Pathol.118: 171–182.
271.
WhiteLR, SteineggerAF, and SchlatterC (1987). Pulmonary response following intratracheal instillation of potroom dust from an aluminum reduction plant into rat lung.Environ. Res.42: 534–545.
272.
WhiteSM, DeNicolaDB, RebarAH, BornGS, and KesslerWV (1988). Effects of chlorphentermine and nitrogen dioxide on murine alveolar macrophages.Exp. Lung Res.14: 619–636.
273.
WiernikA., JohanssonA, JarstrandC, and CamnerP (1983). Rabbit lung after inhalation of soluble nickle. I. Effects on alveolar macrophages.Environ. Res.30: 129–141.
274.
WilkeA., MüllerB, and von WiehertP (1987). Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders.Respiration52: 129–136.
275.
WitschiH., GodfreyG, FromeE, and LindenschmidtRC (1987). Pulmonary toxicity of cytostatic drugs: Cell kinetics.Fundam. Appl. Toxicol.8: 253–262.
276.
WoldJS, JoostRR, GriffingWJ, MarroquineP, and HarrisPN (1976). Phospholipid accumulation in rats produced by fluoxetine and chlorphentermine.Toxicol. Appl. Pharmacol.37: 118–119.
277.
WrightES (1986). Effects of short-term exposure to diesel exhaust on lung cell proliferation and phospholipid metabolism.Exp. Lung Res.10: 39–55.
278.
WrightES, WhiteDM, and SmilerKL (1990). Effects of chronic exposure to ozone on pulmonary lipids in rats.Toxicology64: 313–324.
279.
WrightJR (1990). Clearance and recycling of pulmonary surfactant.Am. J. Physiol.259: L1–L12.
280.
XuZX, SmartDA, and RooneySA (1990). Glu-cocorticoid induction of fatty-acid synthase medi-ates the stimulatory effect of the hormone on choline-phosphate cytidylyltransferase activity in fetal rat lung.Biochim. Biophys. Acta1044: 70–76.
281.
YamamotoA., AdachiS, IshibeT, ShinjiY, Kaki-UchiY, SekiKI, and KitaniT (1970). Accumulation of acidic phospholipids in a case of hyperlipidemia with hepatosplenomegaly.Lipids5: 566–571.
282.
YaoZM, JamilH, and VanceDE (1990). Choline deficiency causes translocation of CTP:phosphocholine cytidylyltransferase from cytosol to endoplasmic reticulum in rat liver.J. Biol. Chem.265: 4326–4331.
283.
ZeitlerP., WuYQ, and HandwergerS (1991). Melittin stimulates phosphoinositide hydrolysis and placental lactogen release: Arachidonic acid as a link between phospholipase A2 and phospholipase C signal-transduction pathways.Life Sci.48:2089–2095.
284.
ZsolnaiB., GyëvaiA, and WeidingerH (1983). Induction of osmiophilic lamellar bodies by corticosteroids, Fenoterol and Ambroxol in lung tissue cultures from human fetuses.Z. Geburtshilfe Perinatol.187: 100–103.
